North America Cancer Therapy Market- Growth, Trends, and Forecasts (2022 - 2027)

The North America Cancer Therapy Market is segmented by Therapy Type, Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Skin Cancer, Respiratory/Lung Cancer), End User, and Geography.

Market Snapshot

Market Snapshot1
Study Period: 2017-2025
Base Year: 2021
CAGR: 8.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North America cancer therapy market is estimated to grow with a CAGR of 8.1% during the forecasted period. Certain factors that are driving the market growth include increasing rising prevalence of cancer, strong R&D initiatives from key players and growing government initiatives for cancer awareness.

In January 2020, the Global Cancer Program hosted the UCSF-Mexico Cancer Collaboration Annual Meeting with partners from Instituto Nacional Cancerologia (INCan), Instituto Nacional de Salud Pública (INSP), and the Instituto Nacional de Medicina Genómica (INMEGEN). The UCSF-Mexico Cancer Initiative aims to strengthen regional cancer research capacity and expand the institutional cancer research portfolios and training activities of partners in Mexico.

According to the Canadian Cancer Society (CCS) 2020 estimates, 225,800 new cases of cancer and 83,300 deaths from cancer are likely to occur in Canada by the end of 2020. On an average, 617 Canadian people are expected to be diagnosed with cancer every day. Thus, owing to above mentioned factors it is expected to show market growth over the forecast period.

Scope of the report

As per the scope of the report, cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, immunotherapy, etc. The North America Cancer Therapy Market is segmented by therapy type, cancer type, end user, and geography.

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Target Therapy Segment is Expected to show the Fastest Growth During the Forecast Period

Targeted therapy is a treatment that uses drugs to target specific genes and proteins that are involved in the growth and survival of cancer cells. It can affect the tissue environment that helps a cancer grow and survive or it can target cells related to cancer growth, like blood vessel cells.

Some of the most common types of targeted therapy are monoclonal antibodies or small-molecule drugs. Moreover, targeted therapies are a rapidly growing field of cancer research and researchers are studying many new targets and drugs through clinical trials.

According to the estimates of the American Cancer Society, in the United States, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths due to cancer in 2018. The most common cancers in the United States are breast cancer, lung cancer, prostate cancer, colorectum cancer, bladder cancer, and skin cancer. Thus, grwoing cases of cancer along with increasing research related to targeted therapies is expected to boost the market growth in coming years.

NA cancer therapy key trend 1.png

Competitive Landscape

The North America cancer therapy market is consolidated. In terms of market share, few of the major players currently dominate the market. Companies, like Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, and Johnson and Johnson, hold significant shares in the cancer therapy market.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Cancer

      2. 4.2.2 Strong R&D Initiatives from Key Players

      3. 4.2.3 Growing Government Initiatives for Cancer Awareness

    3. 4.3 Market Restraints

      1. 4.3.1 Fluctuation in Reimbursement Policies

      2. 4.3.2 High Cost of Cancer Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment Type

      1. 5.1.1 Chemotherapy

      2. 5.1.2 Targeted Therapy

      3. 5.1.3 Immunotherapy

      4. 5.1.4 Hormonal Therapy

      5. 5.1.5 Other Treatment Types

    2. 5.2 By Cancer Type

      1. 5.2.1 Blood Cancer

      2. 5.2.2 Breast Cancer

      3. 5.2.3 Prostate Cancer

      4. 5.2.4 Gastrointestinal Cancer

      5. 5.2.5 Gynecologic Cancer

      6. 5.2.6 Respiratory/Lung Cancer

      7. 5.2.7 Other Cancer Types

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Spcialty Clinics

      3. 5.3.3 Cancer and Radiation Therapy Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Johnson and Johnson

      2. 6.1.2 AstraZeneca PLC

      3. 6.1.3 Merck & Co. Inc.

      4. 6.1.4 Bayer AG

      5. 6.1.5 Amgen Inc

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Eli Lilly and Company

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer Inc

      10. 6.1.10 Bristol Myers Squibb Company

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Cancer Therapy Market market is studied from 2017 - 2025.

The North America Cancer Therapy Market is growing at a CAGR of 8.1% over the next 5 years.

Johnson and Johnson, AstraZeneca PLC, Merck & Co. Inc., Bayer AG, Amgen Inc are the major companies operating in North America Cancer Therapy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!